Malley Thomas
Insider CIK 1403322 · NONE Director · KURA Director · OVAS Director · BGNE Director · KNSA Director · GEVA Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KURA Kura Oncology, Inc. | A Award deriv | 2026-06-04 | 2026-06-04 | 35,000 | — | $0 | 35,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-05-29 | 2026-06-02 | 2,026 | — | $0 | 2,026 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2026-05-29 | 2026-06-02 | 12,158 | — | $0 | 12,158 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2026-05-29 | 2026-06-02 | 2,799 | — | $0 | 15,345 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise deriv | 2026-03-18 | 2026-03-20 | 10,000 | — | $0 | 0 | SEC↗ |
| KURA Kura Oncology, Inc. | M Exercise | 2026-03-18 | 2026-03-20 | 10,000 | $3.12 | $31.2K | 10,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-14 | 2025-08-14 | 33,237 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-14 | 2025-08-14 | 26,236 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-14 | 2025-08-14 | 18,760 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-08-14 | 2025-08-14 | 78,233 | $33.09 | $2.59M | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-14 | 2025-08-14 | 26,236 | $15.19 | $398.5K | 90,779 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-14 | 2025-08-14 | 33,237 | $14.33 | $476.3K | 64,543 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-14 | 2025-08-14 | 18,760 | $15.47 | $290.2K | 31,306 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-13 | 2025-08-14 | 30,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-13 | 2025-08-14 | 20,129 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-08-13 | 2025-08-14 | 50,129 | $33.32 | $1.67M | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-13 | 2025-08-14 | 30,000 | $9.88 | $296.4K | 62,675 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-13 | 2025-08-14 | 20,129 | $10.36 | $208.5K | 32,675 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-12 | 2025-08-14 | 27,448 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-08-12 | 2025-08-14 | 21,959 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-12 | 2025-08-14 | 27,448 | $3.80 | $104.3K | 61,953 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-08-12 | 2025-08-14 | 21,959 | $1.86 | $40.8K | 34,505 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | S Sale | 2025-08-12 | 2025-08-14 | 49,407 | $32.40 | $1.60M | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise deriv | 2025-06-05 | 2025-06-05 | 3,173 | — | $0 | 0 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2025-06-05 | 2025-06-06 | 28,500 | — | $0 | 28,500 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | M Exercise | 2025-06-05 | 2025-06-05 | 3,173 | — | $0 | 12,546 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-06-03 | 2025-06-05 | 16,798 | — | $0 | 16,798 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals In | A Award deriv | 2025-06-03 | 2025-06-05 | 2,799 | — | $0 | 2,799 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2024-06-06 | 2024-06-07 | 4,373 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2024-06-06 | 2024-06-07 | 4,373 | — | $0 | 9,373 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2024-06-05 | 2024-06-07 | 26,000 | — | $0 | 26,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-06-05 | 2024-06-07 | 19,040 | — | $0 | 19,040 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2024-06-05 | 2024-06-07 | 3,173 | — | $0 | 3,173 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise deriv | 2023-06-29 | 2023-07-03 | 5,000 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | M Exercise | 2023-06-29 | 2023-07-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KURA Kura Oncology, Inc. | P Buy | 2023-06-16 | 2023-06-21 | 50,000 | $11.50 | $575.0K | 139,557 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2023-06-15 | 2023-06-20 | 26,975 | — | $0 | 26,975 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2023-06-15 | 2023-06-20 | 12,922 | — | $0 | 46,696 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-06-06 | 2023-06-08 | 26,236 | — | $0 | 26,236 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2023-06-06 | 2023-06-08 | 4,373 | — | $0 | 4,373 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2023-05-31 | 2023-06-02 | 26,000 | — | $0 | 26,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-06-29 | 2022-06-30 | 5,000 | — | $0 | 5,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2022-06-29 | 2022-06-30 | 30,000 | — | $0 | 30,000 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2022-06-22 | 2022-06-24 | 34,645 | — | $0 | 34,645 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2022-06-22 | 2022-06-24 | 16,692 | — | $0 | 33,774 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2022-06-21 | 2022-06-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2021-06-29 | 2021-06-30 | 33,237 | — | $0 | 33,237 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2021-06-22 | 2021-06-23 | 23,000 | — | $0 | 23,000 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2021-06-16 | 2021-06-21 | 17,498 | — | $0 | 17,498 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2021-06-16 | 2021-06-21 | 7,800 | — | $0 | 17,082 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2020-06-30 | 2020-07-02 | 18,760 | — | $0 | 18,760 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2020-06-24 | 2020-06-26 | 23,000 | — | $0 | 23,000 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2020-06-17 | 2020-06-19 | 45,383 | — | $0 | 45,383 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2019-06-25 | 2019-06-27 | 13,000 | — | $0 | 13,000 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2019-06-05 | 2019-06-07 | 64,610 | — | $0 | 64,610 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | A Award deriv | 2019-05-29 | 2019-05-30 | 18,760 | — | $0 | 18,760 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2018-06-07 | 2018-06-08 | 13,000 | — | $0 | 13,000 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2018-06-06 | 2018-06-08 | 17,442 | — | $0 | 17,442 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award | 2018-06-06 | 2018-06-08 | 9,290 | — | $0 | 9,290 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion deriv | 2018-05-29 | 2018-05-29 | 71,967 | — | $0 | 0 | SEC↗ |
| KNSA Kiniksa Pharmaceuticals, L | C Conversion | 2018-05-29 | 2018-05-29 | 71,967 | — | $0 | 71,967 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2017-06-13 | 2017-07-05 | 7,873 | — | $0 | 204,981 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2017-06-09 | 2017-06-12 | 10,000 | — | $0 | 10,000 | SEC↗ |
| BGNE BeiGene, Ltd. | A Award deriv | 2017-06-02 | 2017-06-06 | 169,988 | — | $0 | 169,988 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2017-03-31 | 2017-04-04 | 7,085 | — | $0 | 197,108 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2016-12-30 | 2017-01-04 | 8,660 | $1.53 | $13.2K | 190,023 | SEC↗ |
| BGNE BeiGene, Ltd. | P Buy | 2016-11-23 | 2016-11-28 | 30,000 | $32.00 | $960.0K | 30,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2016-09-30 | 2016-10-04 | 1,850 | — | $0 | 181,363 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2016-06-30 | 2016-07-05 | 2,543 | — | $0 | 179,513 | SEC↗ |
| OVAS OvaScience, Inc. | A Award deriv | 2016-06-02 | 2016-06-06 | 12,000 | — | $0 | 12,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2016-06-01 | 2016-06-03 | 50,000 | $7.00 | $350.0K | 176,970 | SEC↗ |
| KURA Kura Oncology, Inc. | A Award deriv | 2016-05-12 | 2016-05-13 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2016-03-31 | 2016-04-04 | 1,396 | — | $0 | 126,970 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2015-12-31 | 2016-01-05 | 1,356 | — | $0 | 125,574 | SEC↗ |
| KURA Kura Oncology, Inc. | P Buy | 2015-11-10 | 2015-12-17 | 50,000 | $8.00 | $400.0K | 89,557 | SEC↗ |
| KURO Kura Oncology, Inc. | A Award deriv | 2015-10-13 | 2015-10-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2015-09-30 | 2015-10-02 | 1,560 | — | $0 | 124,218 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2015-06-30 | 2015-07-02 | 458 | $28.93 | $13.2K | 122,658 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 7,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 7,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 7,500 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 15,000 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 51 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 2,149 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer deriv | 2015-06-22 | 2015-06-23 | 5,226 | — | $0 | 0 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | D To issuer | 2015-06-22 | 2015-06-23 | 46,901 | — | $0 | 0 | SEC↗ |
| OVAS OvaScience, Inc. | A Award deriv | 2015-06-04 | 2015-06-08 | 12,000 | — | $0 | 12,000 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2015-04-08 | 2015-04-09 | 5,000 | $28.50 | $142.5K | 122,200 | SEC↗ |
| OVAS OvaScience, Inc. | A Award | 2015-03-31 | 2015-04-02 | 381 | $34.73 | $13.2K | 117,200 | SEC↗ |
| OVAS OvaScience, Inc. | P Buy | 2015-01-13 | 2015-01-15 | 35,000 | $50.00 | $1.75M | 116,819 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2014-12-15 | 2014-12-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award deriv | 2014-06-13 | 2014-06-17 | 6,500 | — | $0 | 6,500 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2014-06-04 | 2014-06-05 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2013-12-19 | 2013-12-20 | 10,000 | — | $0 | 10,000 | SEC↗ |
| OVAS OvaScience, Inc. | A Award deriv | 2013-06-07 | 2013-06-11 | 4,448 | — | $0 | 4,448 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2013-06-06 | 2013-06-10 | 7,500 | — | $0 | 7,500 | SEC↗ |
| OVSC OvaScience, Inc. | P Buy | 2013-03-18 | 2013-03-20 | 50,000 | $9.00 | $450.0K | 81,819 | SEC↗ |
| OVAS OvaScience, Inc. | A Award deriv | 2012-10-24 | 2012-10-26 | 13,098 | — | $0 | 13,098 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | P Buy | 2012-10-24 | 2012-10-25 | 10,000 | $16.00 | $160.0K | 156,551 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2012-10-18 | 2012-10-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2012-10-18 | 2012-10-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2012-06-27 | 2012-06-29 | 7,500 | — | $0 | 7,500 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | P Buy | 2012-06-11 | 2012-06-13 | 10,032 | $12.50 | $125.4K | 146,551 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | P Buy | 2012-06-08 | 2012-06-11 | 8,168 | $12.50 | $102.1K | 136,519 | SEC↗ |
| PBYI PUMA BIOTECHNOLOGY, INC. | P Buy | 2012-06-07 | 2012-06-11 | 1,800 | $12.50 | $22.5K | 128,351 | SEC↗ |
| NONE PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2012-02-13 | 2012-02-14 | 30,000 | — | $0 | 30,000 | SEC↗ |
| NONE PUMA BIOTECHNOLOGY, INC. | A Award deriv | 2012-02-13 | 2012-02-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| GEVA SYNAGEVA BIOPHARMA CORP | A Award deriv | 2011-12-20 | 2012-01-11 | 15,000 | — | $0 | 15,000 | SEC↗ |